Clinical Trial Manager II
for section headings (e.g. About the role, Responsibilities, Requirements, Qualifications, Skills, Benefits, Pay, Schedule). We should map content to appropriate headings.
We have "Overview Of Role" -> could be "About the role". We'll use About the role
and put the paragraph.
"Role And Responsibilities" -> Responsibilities
with list.
"Experience, Education And Specialized Knowledge And Skills" -> could be Requirements
or Qualifications
. Since it's experience/education/skills, we can use Qualifications
and list.
Pay: we have pay transparency line. Use Pay
with paragraph.
We must not repeat job title as heading. No Job ID. Remove boilerplate: EEO, referral policy, etc. Also remove "Summit does not accept referrals..." and EEO statement. Also remove "About Summit" maybe? The instruction: "Preserve ALL substantive information; do NOT invent or summarize away detail." The "About Summit" paragraph is substantive? It's about company. Might be considered background but not required? The instruction says we should include sections only when posting has real, specific content for it. The "About Summit" is not a role-specific section; but it's part of the posting. Should we keep it? The instruction says remove cookie/navigation/legal/EEO/equal-opportunity/scam-warning boilerplate, duplicated lines, and application instructions. "About Summit" is not boilerplate; it's company overview. Might be considered substantive. However the instruction about sections: use headings for sections like About the role, Responsibilities, etc. It didn't forbid having a general paragraph before sections. We could include a
for the company overview before sections. It's not a heading. So we can keep that as a
before sections. We must not include "Summit does not accept referrals..." and EEO. We must preserve all substantive information: include details about studies, responsibilities list, qualifications list, pay range. Let's extract content. Company overview paragraph: "About Summit Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s Team Is Inspired To Touch And Help Change Lives Through Summit’s Clinical Studies In The Field Of Oncology. Summit Has Multiple Global Phase 3 Clinical Studies, Including Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland." We'll keep that as a
. Overview Of Role paragraph: "The Clinical Trial Manager 2(CTM2) is an experienced clinical operations professional accountable for all aspects of Clinical Trial Management for global studies. The CTM2 is accountable for study start up and maintenance through study close out, coordinates, leads and drives deliverables for assigned sites, countries, or regions for one or more studies or programs simultaneously. The CTM2s are also accountable for site, country, or region performance metrics and quality of deliverables in the clinical trial." We'll put under
About the role
as. Responsibilities: list of duties. Let's extract bullet points from "Oversee site selection, feasibility, activation, enrollment, monitoring, issue escalation, and closeout activities." etc. We'll convert each sentence to
Responsibilities
with- .
Qualifications/Experience: list from "Experience, Education And Specialized Knowledge And Skills". Let's extract each bullet:
- Bachelor's degree or equivalent in life science, nursing, pharmacy, medical laboratory technology, or other health/medical related area preferred
- 6+ years of clinical trial management experience in conducting international clinical trials in sponsor Pharma/Biotech organization
- 5+ years of direct clinical trial management experience including oversight phase II/III clinical trials.
- Global oncology experience preferred.
- Ability to travel internationally to visit clinical sites and study meetings. Amount will vary upon project needs (up to 20%)
- Demonstrated ability to comprehend complex scientific concepts and proficient in reviewing and assessing clinical data.
- Possesses excellent planning, time management, and project coordination skills.
- Demonstrated ability to identify and manage operational risks and develop effective mitigation strategies.
- Ability to work independently and collaboratively to manage and prioritize work in a fast-paced environment
- Consistently demonstrates the ability to solve problems and use sound judgement in relation to regulatory requirements, interactions with external parties, timelines, and moderately to high clinical programs.
- Strong planning, communication, and organizational skills.
- A solid understanding of the drug development process, ICH guidelines/GCP and specifically, each step within the clinical trial process
We'll put under
- Oversee site selection, feasibility, activation, enrollment, monitoring, issue escalation, and closeout activities.
- Partners with the CRO to ensure robust clinical trial execution, data monitoring strategies, and patient enrollment strategies.
- Drafts, reviews and manages study related plans, processes including Informed Consent Forms, Investigator agreements (CTA), CRFs, CRF guidelines, statistical/pharmacokinetic analysis plans, monitoring plan, data management, and safety monitoring as delegated.
- Reviews and approves essential document packages.
- Tracks and ensures resolution of Risk Based Quality Management actions and signals.
- Conducts sponsor oversight of CRO monitoring activities by reviewing all types of monitoring reports; monitors site performance, identifies quality trends, and ensures timely resolution of monitoring findings and action items.
- Performs quality oversight visits.
- Reviews clinical data listings, reports and dashboards ensuring data currency and completeness inclusive of laboratory, imaging and other protocol required assessments.
- Identifies trends and follows up on outstanding data issues with CRO and Study team.
- Responsible for oversight on the maintenance and completeness of the TMF, performing periodic quality reviews.
- Oversee the creation and execution of clinical trial activities in accordance with Good Clinical Practices.
- Ensure compliance of clinical trials with national and international regulatory requirements.
- Ensures inspection readiness.
- Mentors and provides guidance to CTMs, CRAs, and other Clinical Operations team members.
- All other duties as assigned.
- Bachelor's degree or equivalent in life science, nursing, pharmacy, medical laboratory technology, or other health/medical related area preferred
- 6+ years of clinical trial management experience in conducting international clinical trials in sponsor Pharma/Biotech organization
- 5+ years of direct clinical trial management experience including oversight phase II/III clinical trials.
- Global oncology experience preferred.
- Ability to travel internationally to visit clinical sites and study meetings. Amount will vary upon project needs (up to 20%)
- Demonstrated ability to comprehend complex scientific concepts and proficient in reviewing and assessing clinical data.
- Possesses excellent planning, time management, and project coordination skills.
- Demonstrated ability to identify and manage operational risks and develop effective mitigation strategies.
- Ability to work independently and collaboratively to manage and prioritize work in a fast-paced
Qualifications
with- .
Pay: we have "This is the pay for this position Pay Transparency $122,000 - $145,000 USD Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation."
We'll put under
Pay
with. We must not include Benefits or Schedule sections as not present. We must not include duplicated lines. Ensure we didn't include referral policy or EEO. Now output HTML fragment. Let's craft:
About Summit Summit Therapeutics Inc....
About the role
The Clinical Trial Manager 2(CTM2) is an experienced clinical operations professional accountable for all aspects of Clinical Trial Management for global studies. The CTM2 is accountable for study start up and maintenance through study close out, coordinates, leads and drives deliverables for assigned sites, countries, or regions for one or more studies or programs simultaneously. The CTM2s are also accountable for site, country, or region performance metrics and quality of deliverables in the clinical trial.